History

This is the footstep of Korea's APIs industry,
which CKD BiO has grown and nurtured.

2000s

"Spreading the roots of APIs"

2009 Cyclosporine’s CEP granted by EDQM
2008 GMP approval by Italy AIFA
(Potassium Clavulanate, Cyclosporine, Teicoplanin)
Acarbose’s CEP granted by EDQM
GMP approval by Japan PMDA(Acarbose)
2007 GMP approval by US FDA
(Potassium Clavulanate , DMCT, Rifampicin)
2005 Potassium Clavulanate’s CEP granted by EDQM
2004 Potassium Clavulanate designated as "World-class Product"
(Ministry of Trade, Industry and Energy, Korea)
2001 GMP approval by US FDA(Rifampicin)
Awarded "The 5th Environmental Technology Presidential Award"
(Ministry of Environment, Korea)
for developing enzymatic-production process of 7-ACA
Spun-off from “Chong Kun Dang Corp.”